Hydroxyphenyl cross-linked macromolecular network and applications thereof
AssigneeThe Cleveland Clinic Foundation
InventorsPeter A. Zahos, Anthony Calabro, Aniq B. Darr, Richard A. Gross
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Cleveland Clinic Foundation
InventorsPeter A. Zahos, Anthony Calabro, Aniq B. Darr, Richard A. Gross
Estimating the term…
A synthetic nucleus pulposus is provided that is useful in treatment of degenerative disc disease, augmentation of a degenerate disc, and alleviation of back pain. In an embodiment the synthetic nucleus pulposus comprises hyaluronan macromolecules that have been cross-linked via dihydroxyphenyl linkages. The synthetic nucleus pulposus restores or improves the water-retention capability of the disc. A method of treating an intervertebral disc with the cross-linked hyaluronan macromolecules is also provided. A method of regenerative therapy to address loss of cells of nucleus pulposus of an intervertebral disc based on treatment with the cross-linked hyaluronan macromolecules and mesenchymal stem cells is also provided.
A synthetic nucleus pulposus, said synthetic nucleus pulposus comprising polycarboxylate, polyamine, or polyhydroxyphenyl macromolecules that have been cross-linked via dihydroxyphenyl linkages.
A method of treating an intervertebral disc, said method comprising injection, within said intervertebral disc, of polycarboxylate, polyamine, or polyhydroxyphenyl macromolecules that have hydroxyphenyl side groups thereon.
A method of regenerative therapy for an intervertebral disc comprising injection, within said intervertebral disc, of a composition comprising polycarboxylate, polyamine, or polyhydroxyphenyl macromolecules that have hydroxyphenyl side groups thereon together with mesenchymal stem cells.
Dependencies are inferred from the claim text.